Literature DB >> 6328347

Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.

J C Buckingham, T A Cooper.   

Abstract

The influence of opioid substances on the secretion in vivo and in vitro of corticosterone, corticotrophin (ACTH) and corticotrophin releasing factor (CRF) in the rat was studied. Rats given a single injection of morphine exhibited a marked hypersecretion of ACTH and an exaggeration of the hypothalamo-pituitary-adrenocortical (HPA) response to stress. In contrast, animals rendered tolerant to morphine failed to release ACTH or corticosterone in response either to a subsequent injection of the opiate or to stress. The development of the inhibitory effect paralleled the development of tolerance to the analgesic actions of the drug. The production of ACTH by pituitary segments removed from control animals was not affected by the addition of opioid substances to the incubation medium. However, morphine, met-enkephalin and leu-enkephalin stimulated the secretion of CRF by hypothalami and their effects were competitively antagonized by naloxone. The secretory activity of hypothalami removed from rats treated acutely with morphine was enhanced. In contrast hypothalami from morphine-tolerant rats failed to secrete CRF in response to morphine, met-enkephalin, acetylcholine or 5-hydroxytryptamine. Neither the density nor the affinity of 3H-naloxone binding sites in the hypothalamus was influenced by the morphine treatment. The results suggest the opioid peptides and their receptors play a major role in the regulation of HPA function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328347     DOI: 10.1159/000123927

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  27 in total

1.  Cortical 3 alpha-hydroxy-5 alpha-pregnan-20-one levels after acute administration of Delta 9-tetrahydrocannabinol, cocaine and morphine.

Authors:  A Chistina Grobin; Margaret J VanDoren; Linda J Porrino; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

2.  Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens.

Authors:  Michael J Glass; Diane A Lane; Eric E O Colago; June Chan; Stefan D Schlussman; Yan Zhou; Mary Jeanne Kreek; Virginia M Pickel
Journal:  Exp Neurol       Date:  2008-01-26       Impact factor: 5.330

Review 3.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

Review 4.  Effects of opioids on the parental brain in health and disease.

Authors:  James E Swain; S Shaun Ho; Helen Fox; David Garry; Susanne Brummelte
Journal:  Front Neuroendocrinol       Date:  2019-05-22       Impact factor: 8.606

5.  Transgenerational blunting of morphine-induced corticosterone secretion is associated with dysregulated gene expression in male offspring.

Authors:  Fair M Vassoler; Anika M Toorie; Elizabeth M Byrnes
Journal:  Brain Res       Date:  2017-11-10       Impact factor: 3.252

6.  Immobilization stress-induced oral opioid self-administration and withdrawal in rats: role of conditioning factors and the effect of stress on "relapse" to opioid drugs.

Authors:  Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.

Authors:  S L Lightman; W S Young
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

Review 8.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

9.  Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats.

Authors:  E C degli Uberti; F Petraglia; M Bondanelli; A L Guo; A Valentini; S Salvadori; M Criscuolo; R E Nappi; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

10.  Effects of prenatal morphine on hypothalamic metabolism of neurotransmitters and gonadal and adrenal activities, during the early postnatal period in the rat.

Authors:  J Lesage; F Bernet; V Montel; J P Dupouy
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.